| Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema. | |
| | |
MedLine Citation:
|
PMID: 21765371 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To compare the efficacy and safety of intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema. METHODS: Thirty-two eyes with diffuse diabetic macular edema were randomly allocated to intravitreal injection of 4 mg/0.1 mL of triamcinolone (Group 1: N = 16) or 500 μg/0.1 mL of diclofenac (Group 2: N = 16). Preoperative and postoperative visual acuity, intraocular pressure, and central macular thickness were recorded and compared between the 2 groups up to 12 weeks. RESULTS: Both groups showed statistically significant reduction in central macular thickness (triamcinolone: P = 0.02 and diclofenac: P = 0.01), without statistically significant difference between the 2 groups. Visual improvement was significant only in triamcinolone group (P = 0.05). However, the 2 groups showed no statistically significant difference in mean visual acuity or mean line improvement. Transient elevation of intraocular pressure occurred in 12.5% of the triamcinolone group. Diclofenac group showed statistically significant reduced intraocular pressure (P = 0.02). CONCLUSION: Intravitreal diclofenac is effective in the treatment of diffuse diabetic macular edema up to 12 weeks. Intravitreal triamcinolone and diclofenac appear to have comparable therapeutic effects on retinal thickness. The degree of visual improvement is higher with triamcinolone. |
| | |
Authors:
|
Amal M Elbendary; Maha M Shahin |
Publication Detail:
|
Type: Comparative Study; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Retina (Philadelphia, Pa.) Volume: 31 ISSN: 1539-2864 ISO Abbreviation: Retina (Philadelphia, Pa.) Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-10-26 Completed Date: 2012-02-24 Revised Date: 2012-06-05 |
Medline Journal Info:
|
Nlm Unique ID: 8309919 Medline TA: Retina Country: United States |
Other Details:
|
Languages: eng Pagination: 2058-64 Citation Subset: IM |
Affiliation:
|
Mansoura Ophthalmic Center, Mansoura University, Mansoura, Egypt. amalelbendary67@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anti-Inflammatory Agents, Non-Steroidal / adverse effects, therapeutic use* Diabetic Retinopathy / drug therapy*, physiopathology Diclofenac / adverse effects, therapeutic use* Female Glucocorticoids / adverse effects, therapeutic use* Humans Intraocular Pressure / physiology Intravitreal Injections Macula Lutea / pathology Macular Edema / drug therapy*, physiopathology Male Middle Aged Tomography, Optical Coherence Treatment Outcome Triamcinolone Acetonide / adverse effects, therapeutic use* Visual Acuity / physiology |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Glucocorticoids; 15307-86-5/Diclofenac; 76-25-5/Triamcinolone Acetonide |
| Comments/Corrections | |
Comment In:
|
Retina. 2012 May;32(5):1033; author reply 1033-4
[PMID:
22495330
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Placido-Based Indices of Corneal Irregularity.
Next Document: INCIDENCE OF, RISK FACTORS FOR, AND COMBINED MECHANISM OF LATE-ONSET OPEN-ANGLE GLAUCOMA AFTER VITRE...